Pasithea Therapeutics News

Pasithea Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Marques Tiago

Apr 5 21:49 ET

Pasithea Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Dumesnil Simon

Apr 5 21:49 ET

Pasithea Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Schneiderman Daniel H

Apr 5 21:49 ET

Pasithea Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Leahy Emer

Apr 5 21:49 ET

Pasithea Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Novak Alfred J

Apr 5 21:49 ET

Pasithea Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Currie Graeme Martin

Apr 5 21:49 ET

Pasithea Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director STEINMAN LAWRENCE

Apr 5 21:49 ET

Pasithea Therapeutics | EFFECT: Others

Apr 3 06:07 ET

Pasithea Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 29 16:33 ET

Pasithea Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Mar 29 12:54 ET

Pasithea Therapeutics | 10-K: Annual report

Mar 29 12:54 ET

Pasithea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director STEINMAN LAWRENCE

Mar 1 21:50 ET

Pasithea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Schneiderman Daniel H

Mar 1 21:50 ET

Pasithea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Novak Alfred J

Mar 1 21:50 ET

Pasithea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Marques Tiago

Mar 1 21:50 ET

Pasithea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Leahy Emer

Mar 1 21:50 ET

Pasithea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Dumesnil Simon

Mar 1 21:50 ET

Pasithea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Currie Graeme Martin

Mar 1 21:50 ET

Pasithea Therapeutics | 8-K: Current report

Jan 18 00:00 ET

Pasithea Therapeutics | 8-K: Current report

Jan 2 00:00 ET